Feds aim to streamline gene therapy oversightAugust 16, 2018Practice ManagementImmuno-oncologyGene Therapy
Phase 2 trial: Dendritic cell vaccine maintenance prolongs PFS in EOCJuly 30, 2018Gynecologic CancerImmuno-oncology
Third-line avelumab for gastric cancer safer than chemotherapyJuly 27, 2018Immuno-oncologyGastroenterologyGastrointestinal Cancer
No survival boost with atezolizumab vs. regorafenib in mCRCJuly 18, 2018GastroenterologyImmuno-oncologyGastrointestinal Cancer
FDA grants accelerated approval to ipilimumab/nivolumab combo for CRCJuly 13, 2018Immuno-oncologyGastroenterologyGastrointestinal Cancer
Immunotherapies extend survival for melanoma patients with brain metastasesJuly 12, 2018Immuno-oncologyNeuro-oncologyCNS/Brain CancerMelanoma
Checkpoint inhibitors in autoimmune disease: More flares, better cancer outcomesJune 25, 2018Immuno-oncologyImmunotherapy
KEYNOTE-427: Pembrolizumab monotherapy shows promise in accRCCJune 25, 2018Renal Cell CarcinomaGenitourinary CancerImmuno-oncology
Hints of nivolumab efficacy seen in biliary tract cancersJune 25, 2018GastroenterologyImmuno-oncologyGastrointestinal Cancer
Pembrolizumab does not surpass paclitaxel for gastric cancerJune 21, 2018Immuno-oncologyGastroenterologyGastrointestinal Cancer
Blood and tissue TMB help predict checkpoint inhibition response in NSCLCJune 21, 2018Immuno-oncologyLung Cancer
